Kunneman M, Marijnen C A M, Rozema T, Ceha H M, Grootenboers D A R H, Neelis K J, Stiggelbout A M, Pieterse A H
Leiden University Medical Center, Department of Medical Decision Making, PO Box 9600, 2300 RC Leiden, The Netherlands.
Leiden University Medical Center, Department of Clinical Oncology, PO Box 9600, 2300 RC Leiden, The Netherlands.
Br J Cancer. 2015 Jan 6;112(1):39-43. doi: 10.1038/bjc.2014.546. Epub 2014 Oct 21.
For shared decision making to be successful, patients should receive sufficient information on possible benefits and harms of treatment options. The aim of this study was to evaluate what information radiation oncologists provide during the decision consultation about preoperative radiotherapy with rectal cancer patients.
Decision consultations of 17 radiation oncologists with 81 consecutive primary rectal cancer patients, eligible for short-course radiotherapy followed by a low-anterior resection, were audio taped. Tapes were transcribed and analysed using the ACEPP (Assessing Communication about Evidence and Patient Preferences) coding scheme.
A median of seven benefits/harms were addressed per consultation (range, 2-13). This number ranged within and between oncologists and was not clearly associated with the patient's characteristics. A total of 30 different treatment outcomes were addressed. The effect of radiotherapy on local control was addressed in all consultations, the effect on survival in 16%. The most important adverse effects are bowel and sexual dysfunction. These were addressed in 82% and 85% of consultations, respectively; the latter significantly less often in female than in male patients. Four out of five patients did not initiate discussion on any benefits/harms.
Our results showed considerable inconsistency between and within oncologists in information provision, which could not be explained by patient characteristics. This variation indicates a lack of clarity on which benefits/harms of radiotherapy should be discussed with newly-diagnosed patients. This suboptimal patient information hampers the process of shared decision making, in which the decision is based on each individual patients' weighing of benefits and harms.
为使共同决策取得成功,患者应获得关于治疗方案可能的益处和危害的充分信息。本研究的目的是评估放射肿瘤学家在与直肠癌患者进行术前放疗决策咨询时提供了哪些信息。
对17名放射肿瘤学家与81例连续的原发性直肠癌患者进行决策咨询的过程进行了录音,这些患者符合短程放疗后行低位前切除术的条件。对录音进行转录,并使用ACEPP(评估关于证据和患者偏好的沟通)编码方案进行分析。
每次咨询讨论的益处/危害中位数为7项(范围为2 - 13项)。这个数字在肿瘤学家之间以及内部都有所不同,并且与患者的特征没有明显关联。总共讨论了30种不同的治疗结果。所有咨询中都提到了放疗对局部控制的影响,16%的咨询提到了对生存的影响。最重要的不良反应是肠道和性功能障碍。在82%和85%的咨询中分别提到了这两种不良反应;后者在女性患者中的提及频率明显低于男性患者。五分之四的患者没有主动讨论任何益处/危害。
我们的结果显示,肿瘤学家在信息提供方面存在显著的内部和之间的不一致,这无法用患者特征来解释。这种差异表明在与新诊断患者讨论放疗的哪些益处/危害方面缺乏明确性。这种对患者信息提供不足的情况阻碍了共同决策过程,在共同决策中,决策是基于每个患者对益处和危害的权衡。